Insights / Physician specialty marketing

Gastroenterology practice marketing: screening pages, cost wording, recall and reviews

How a GI practice can market colorectal screening and digestive care accurately: USPSTF ages, Medicare cost wording, recall messages, reviews and tracking.

A gastroenterology practice markets something most people would rather put off. Patients arrive through primary care referrals, through screening reminders, and through searches made late at night about symptoms they have not mentioned to anyone. That mix makes GI marketing unusual: much of the most useful content is about prevention, the cost question is often the deciding one, and the pages patients read are about conditions they consider private.

This guide covers how to write screening pages that match the federal recommendation, how to describe colonoscopy costs without promising “free”, how recall messages fit HIPAA, how to handle patient stories and reviews, and where tracking tags do not belong on a GI site. It does not cover clinical choices such as which screening test suits a patient, or bowel preparation; those belong to the clinician.

This is general information, not legal or medical advice. Sources cited were checked on October 29, 2026: the US Preventive Services Task Force final recommendation on colorectal cancer screening (May 18, 2021); Medicare.gov, Colonoscopies (screening); the FTC Health Products Compliance Guidance (December 2022); 16 CFR 255.2; 16 CFR Part 465; and 45 CFR 164.501, 164.508 and 164.522. Coverage rules for private plans vary, and Medicare details change, so check the current pages before publishing cost wording.

Write screening pages around the recommendation, not around a slogan

Most GI marketing starts with colorectal cancer screening, and the reference point is the US Preventive Services Task Force. Its final recommendation, dated May 18, 2021, says:

  • Adults aged 50 to 75: the USPSTF recommends screening for colorectal cancer (grade A).
  • Adults aged 45 to 49: the USPSTF recommends screening (grade B). This was the change in 2021; the earlier recommendation started at 50.
  • Adults aged 76 to 85: clinicians should selectively offer screening, considering the patient’s overall health, prior screening history and preferences (grade C).

Two details in that recommendation matter for how you write. First, it applies to adults without signs or symptoms of colorectal cancer who are at average risk, meaning no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no known genetic disorder that puts them at high lifetime risk. A screening page that says “Book your colonoscopy at 45” with nothing else speaks to everyone, including people with symptoms who need to be seen rather than screened. Say who the recommendation is for, and give people with symptoms or a strong family history a clear next step: talk to a clinician.

Second, the USPSTF describes several screening strategies, including stool-based tests and direct visualization tests. A page that implies colonoscopy is the only real option does not match the recommendation. You can explain why your practice offers colonoscopy and what to expect, and still say that other recommended tests exist and that the choice is made with a clinician.

Date the page and name the source. When the recommendation is updated, the page needs updating too, and a visible “reviewed on” date tells readers and reviewers that someone checks.

Do not promise a free colonoscopy

“Free colonoscopy” is an easy headline and a risky one. Medicare.gov says Part B covers screening colonoscopies, and if the provider accepts assignment, the patient pays nothing for the screening test. But the same page says that if the provider finds and removes a polyp or other tissue during the colonoscopy, the patient pays 15% of the Medicare-approved amount for the provider’s services, and in a hospital outpatient setting or ambulatory surgical center also pays the facility a 15% coinsurance. The Part B deductible does not apply.

Other details on that page are useful for patient education:

  • Follow-up after a positive stool or blood test. If a patient first has a Medicare-covered non-invasive stool-based test or blood-based biomarker test and gets a positive result, Part B also covers a follow-up colonoscopy as a screening test.
  • How often. Once every 24 months for people at high risk. For people not at high risk, once every 120 months, or 48 months after a previous flexible sigmoidoscopy.
  • No minimum age. Medicare.gov says there is no minimum age requirement for the screening.

FTC staff guidance in the Health Products Compliance Guidance says the net impression of the whole ad is what counts, and qualifiers do not cure a misleading claim. “Free” in large type with “polyp removal may cost extra” in small type is the pattern to avoid. Better wording describes the screening cost and the possible extra cost together, in the same place and the same size, for example: “Medicare covers screening colonoscopy with no cost for the screening itself when your provider accepts assignment. If a polyp is removed, coinsurance applies.” For patients with private insurance, do not generalize; tell them to check with their plan or call the office.

If you also see self-pay patients, the No Surprises Act requires a good faith estimate for uninsured and self-pay patients; see our guide to the good faith estimate and to advertising cash prices.

Build pages for the conditions people search for

Beyond screening, people search for symptoms and conditions: reflux, swallowing problems, abdominal pain, liver conditions, inflammatory bowel disease. A page for each condition you treat, written for patients, can help the right patients find the right practice. Each page should explain the condition in plain language with a cited source, say what an appointment involves, who at the practice treats it, and how to get a referral if one is needed.

Keep these pages informational. Do not promise a cure, a symptom-free life or a result from a procedure, and do not compare your outcomes with other practices unless you can substantiate the comparison. The FTC guidance requires competent and reliable scientific evidence for health claims. Our guide on writing a medical practice blog covers where general information ends and individual medical advice begins.

Patients with GI symptoms are often embarrassed, so tone matters. Plain words, a calm explanation of what happens at the first visit and clear information about privacy will usually do more than urgency. Avoid fear-based copy that implies a reader probably has cancer.

Liver conditions need their own care in marketing, from how to state the hepatitis C cure to keeping detox claims off the site. Our hepatology practice marketing guide covers them.

Recall and reminder messages

Many GI patients are due for a repeat screening or surveillance colonoscopy at an interval their clinician set, so recall messages matter. Under HIPAA, these messages are usually not marketing. The definition of marketing at 45 CFR 164.501 excludes communications for the patient’s treatment and communications describing health-related services the practice itself provides, as long as the practice is not paid by a third party to send them. Our guide to patient recall systems covers the details.

Two cautions. The interval is the clinician’s decision, not a marketing setting, so the recall date should come from the chart, not from a campaign. And under 45 CFR 164.522(b), patients can ask to be contacted by other means or at another address; a postcard that says “time for your colonoscopy” may be exactly what some patients asked you not to send. Respect those flags in every tool that sends reminders.

Patient stories and reviews

A patient who says the procedure was easier than expected can reassure others. Using that story in marketing brings three rules into play:

  1. Authorization. If the practice is a HIPAA covered entity, using a patient’s story, photo or name in marketing generally needs the patient’s written authorization under 45 CFR 164.508. See our guide to HIPAA marketing rules.
  2. Typical results. Under 16 CFR 255.2(b), an ad that presents one patient’s experience on a key point is likely to be read as what patients generally experience. Unless you can substantiate that, the ad should clearly disclose what patients can generally expect.
  3. Reviews. 16 CFR Part 465 prohibits fake reviews and, in section 465.4, incentives conditioned on a review expressing a particular sentiment. Ask every patient for honest feedback, not only the happy ones.

When a patient posts a negative review about a procedure, do not confirm they are a patient or discuss their care in the reply. Our guide to HIPAA and negative review replies covers what happened to practices that did.

Tracking on condition pages and booking forms

A GI site has many pages whose subject alone is sensitive: a colonoscopy booking form, a page about inflammatory bowel disease, a symptom checker. Before adding advertising pixels or session recording to these pages, read our guides to tracking pixels on practice websites and cookie consent banners. Measure calls and form submissions as events, and keep patient details out of ad and analytics tools.

Referrals from primary care

Many GI patients arrive by referral, so the practice’s relationships with primary care offices are part of its marketing. Make it easy for referring offices: a referral page with what to send, a direct line, and quick reports back. Paying for or rewarding referrals can raise federal Anti-Kickback Statute problems where federal health care program business is involved; our guide to patient and physician referrals covers those limits.

GI marketing ideas that work inside the rules

  • A screening page by age. What the USPSTF recommends at 45 to 49, 50 to 75 and 76 to 85, with the source and a review date.
  • A cost page with both halves. What Medicare covers, when coinsurance applies, and a phone number for private insurance questions.
  • A first-visit page. What happens at the appointment, how long it takes and what to bring, without preparation instructions that belong to the clinician.
  • Condition pages for what you treat, each with a source and a named reviewer.
  • A referral page for primary care offices.
  • Accurate local listings. Each office and procedure location with correct hours and phone; see our guide to Google Business Profile for doctors.

A practice that runs an inflammatory bowel disease program has its own wording to get right: cure and remission, urgent symptoms, diet and supplement claims, and teens moving to adult care. Our guide to IBD center marketing covers each of those.

How we can help

We build and optimize websites for independent practices, including screening, condition and cost pages written from primary sources and reviewed by your clinicians before they go live. We do not promise rankings or patient numbers. See our healthcare SEO service.

At what age should our screening page say colorectal screening starts?

The USPSTF final recommendation from May 18, 2021 recommends screening for average-risk adults without symptoms aged 45 to 75, with selective screening from 76 to 85. Say who the recommendation applies to, and send people with symptoms or a higher risk to a clinician.

Can we advertise free screening colonoscopies to Medicare patients?

Avoid the bare word free. Medicare.gov says the patient pays nothing for the screening when the provider accepts assignment, but 15% coinsurance applies to the provider’s services, and a facility coinsurance in a hospital outpatient department or surgery center, if a polyp or tissue is removed. Put both facts together.

Is a colonoscopy recall letter marketing under HIPAA?

Usually not. 45 CFR 164.501 excludes communications for the patient’s treatment and about services the practice itself provides, as long as no third party pays the practice to send them. Respect any confidential communication requests.

Can we only mention colonoscopy on our screening page?

You can explain what you offer, but the USPSTF describes several recommended strategies, including stool-based tests. Say that other options exist and that the test is chosen with a clinician.

Can we share a patient’s story about their procedure?

If you are a HIPAA covered entity, you generally need the patient’s written authorization. Under 16 CFR 255.2(b), one patient’s experience is likely to be read as typical unless you can substantiate that or disclose what patients generally experience.

Sources

More in Physician specialty marketing

Want a second pair of eyes on your patient path?

Book a practice review. We look at how patients find you, what they see on your site, what happens when they call, and what you can measure today. You get a plain list of what we would fix first.